Mr. Robert Friedman

Mr. Robert Friedman teaches Business & Finance. During his consulting career, he led and executed hundreds of business-oriented projects including strategy, market assessment, and business development plans covering pharmaceuticals, biotechnology, and medical devices. He has performed due diligence assignments on dozens of acquisition and licensing candidates. Mr. Friedman’s particular interest was in the flourishing life sciences market in Israel where he has conducted about two dozen discrete assignments. These engagements included diligence work for U.S. companies interested in Israeli technology as well as assessments and entry strategies into the U.S. market. Prior to his career in management consulting, Mr. Friedman worked on Wall Street where he was a Senior Equities Analyst in biotechnology, during which time he initiated and maintained coverage of a dozen large- and small-cap biotechnology companies and tracked a universe of approximately 75 companies, primarily in biopharmaceuticals. He also spent two years at the venture capital firm, Steinberg & Lyman Healthcare Ventures (now called HealthCare Ventures LLC). He founded and wrote the business plans for several new startups including Genetic Therapy, Inc., which was acquired by Novartis. Mr. Friedman earned his B.A. in biology from Yeshiva University and holds an M.B.A. from the Johnson School of Management, Cornell University, with a focus on finance and marketing. He is the father of three sons, two of whom are TABC alumni: Nachi ‘05, Simi, and Coby ‘09.